| Literature DB >> 3843217 |
F J Vajda, P F Bladin, B J Parsons.
Abstract
A benzodiazepine drug, clobazam, was evaluated in 14 refractory epileptic patients, nine of whom received the drug double-blind. Ten patients have been given clobazam long enough to assess results. Four showed marked benefit, four failed to respond and two showed a transient benefit which was maintained by dose changes of both clobazam and clonazepam. Side effects were minimal; doses ranged from 15 to 60 mg per day. Clobazam may have place in the treatment of the Lennox Gastaut syndrome and other types of refractory seizures.Entities:
Mesh：
Substances：
Year: 1985 PMID： 3843217
Source DB: PubMed Journal: Clin Exp Neurol ISSN： 0196-6383